M&A Boom Keeping Biotech Investors Hungry After Wave of IPOs

Now watching

Next video starts in : 7 Play

M&A Boom Keeping Biotech Investors Hungry After Wave of IPOs

M&A Boom Keeping Biotech Investors Hungry After Wave of IPOs
Replay video
Up next

Stocks Slump as Biotech Sector Drags Nasdaq From Records

Unlock your personal NFL Now stream by signing in to NFL.com

M&A Boom Keeping Biotech Investors Hungry After Wave of IPOs

by TheStreet 1:58 mins

M&A Boom Keeping Biotech Investors Hungry After Wave of IPOs

by TheStreet 1:58 mins

Biotech companies raised $4.7 billion globally from 68 IPOs during the first half of 2014, and investor appetite will remain strong the rest of the year, said Greg Sarian, Partner at HighTower in Philadelphia. Sarian said there are 41 companies that have publicly filed to complete IPOs in the coming months and there remains a high level of interest in specialty biotech given the ongoing stream of M&A announcements. Furthermore, Sarian said that Federal Reserve Chair Janet Yellen's comment about stretched valuations in biotech stocks can be countered by strong Q2 earnings performances.

TheStreet

Market Movers

  1. 13:30

    Wall Street's record followup; Apple earnings preview; Chipotle's GMO-free menu

  2. 2:41

    Apple Earnings Preview

  3. 3:13

    Chipotle removes GMO products from menu

  4. 2:51

    Pharmaceutical companies increase drug prices: WSJ Report

  5. 1:52

    Apple jumps ahead of earnings; Applied Materials merger falls apart; Deutsche Bank overhaul plan

  6. 14:30

    Nasdaq set to top record; Apple Watch deliveries; Comcast abandons merger